Literature DB >> 28620373

Mechanisms of Autoantibody-Induced Pathology.

Ralf J Ludwig1, Karen Vanhoorelbeke2, Frank Leypoldt3,4,5, Ziya Kaya6, Katja Bieber1, Sandra M McLachlan7, Lars Komorowski8, Jie Luo9, Otavio Cabral-Marques10, Christoph M Hammers11, Jon M Lindstrom9, Peter Lamprecht10, Andrea Fischer6, Gabriela Riemekasten10, Claudia Tersteeg2, Peter Sondermann12, Basil Rapoport7, Klaus-Peter Wandinger13, Christian Probst8, Asmaa El Beidaq14, Enno Schmidt1, Alan Verkman15,16, Rudolf A Manz14, Falk Nimmerjahn17.   

Abstract

Autoantibodies are frequently observed in healthy individuals. In a minority of these individuals, they lead to manifestation of autoimmune diseases, such as rheumatoid arthritis or Graves' disease. Overall, more than 2.5% of the population is affected by autoantibody-driven autoimmune disease. Pathways leading to autoantibody-induced pathology greatly differ among different diseases, and autoantibodies directed against the same antigen, depending on the targeted epitope, can have diverse effects. To foster knowledge in autoantibody-induced pathology and to encourage development of urgently needed novel therapeutic strategies, we here categorized autoantibodies according to their effects. According to our algorithm, autoantibodies can be classified into the following categories: (1) mimic receptor stimulation, (2) blocking of neural transmission, (3) induction of altered signaling, triggering uncontrolled (4) microthrombosis, (5) cell lysis, (6) neutrophil activation, and (7) induction of inflammation. These mechanisms in relation to disease, as well as principles of autoantibody generation and detection, are reviewed herein.

Entities:  

Keywords:  B cells; autoantibodies; autoimmunity; diagnosis; mouse models; pathogenesis; treatment

Year:  2017        PMID: 28620373      PMCID: PMC5449453          DOI: 10.3389/fimmu.2017.00603

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  482 in total

Review 1.  The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease.

Authors:  S M McLachlan; B Rapoport
Journal:  Endocr Rev       Date:  1992-05       Impact factor: 19.871

Review 2.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Authors:  Marios C Papadopoulos; Jeffrey L Bennett; Alan S Verkman
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

3.  Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.

Authors:  Evaren E Page; Johanna A Kremer Hovinga; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood       Date:  2016-04-08       Impact factor: 22.113

Review 4.  Pemphigoid diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Lancet       Date:  2012-12-11       Impact factor: 79.321

Review 5.  Acetylcholine receptors and myasthenia.

Authors:  J M Lindstrom
Journal:  Muscle Nerve       Date:  2000-04       Impact factor: 3.217

6.  Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function.

Authors:  K Schulze; B F Becker; R Schauer; H P Schultheiss
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

7.  Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.

Authors:  Paul Sanders; Stuart Young; Jane Sanders; Katarzyna Kabelis; Stuart Baker; Andrew Sullivan; Michele Evans; Jill Clark; Jane Wilmot; Xiaoling Hu; Emma Roberts; Michael Powell; Ricardo Núñez Miguel; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  J Mol Endocrinol       Date:  2011-02-15       Impact factor: 5.098

8.  Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice.

Authors:  B Rock; R S Labib; L A Diaz
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

9.  Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18.

Authors:  Judith Rademacher; Angela Kill; Kathrin Mattat; Duska Dragun; Elise Siegert; Jeannine Günther; Gabriela Riemekasten
Journal:  J Rheumatol       Date:  2016-01-15       Impact factor: 4.666

10.  Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita.

Authors:  Christoph T Ellebrecht; Girish Srinivas; Katja Bieber; David Banczyk; Kathrin Kalies; Sven Künzel; Christoph M Hammers; John F Baines; Detlef Zillikens; Ralf J Ludwig; Jürgen Westermann
Journal:  J Autoimmun       Date:  2015-09-01       Impact factor: 7.094

View more
  145 in total

1.  Immunity against cancer cells may promote their proliferation and metastasis.

Authors:  Chih-Wei Lin; Jia Xie; Ding Zhang; Kyung Ho Han; Geramie Grande; Nicholas C Wu; Zhuo Yang; Kyungmoo Yea; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

2.  [85-year-old male with cutaneous blisters : Preparation for the medical specialist examination: Part 25].

Authors:  Mareike Witte; Enno Schmidt; Ralf Ludwig
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

3.  [32-year-old female, pregnant and with pruritic rash : Preparation for the medical specialist examination: Part 4].

Authors:  Falk Ochsendorf
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

4.  Hyperthyroidism After Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study.

Authors:  Peter D Inskip; Lene H S Veiga; Alina V Brenner; Alice J Sigurdson; Evgenia Ostroumova; Eric J Chow; Marilyn Stovall; Susan A Smith; Wendy Leisenring; Leslie L Robison; Gregory T Armstrong; Charles A Sklar; Jay H Lubin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-12       Impact factor: 7.038

Review 5.  Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention.

Authors:  Camille Jacqueline; Olivera J Finn
Journal:  Semin Immunol       Date:  2020-04-06       Impact factor: 11.130

6.  Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.

Authors:  Kenta Nakama; Hiroshi Koga; Norito Ishii; Chika Ohata; Takashi Hashimoto; Takekuni Nakama
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

7.  Walnut antigens can trigger autoantibody development in patients with pemphigus vulgaris through a "hit-and-run" mechanism.

Authors:  Lan Lin; Timothy P Moran; Bin Peng; Jinsheng Yang; Donna A Culton; Huilian Che; Songsong Jiang; Zhi Liu; Songmei Geng; Yuzhu Zhang; Luis A Diaz; Ye Qian
Journal:  J Allergy Clin Immunol       Date:  2019-05-06       Impact factor: 10.793

Review 8.  Pathologic conditions of hard tissue: role of osteoclasts in osteolytic lesion.

Authors:  Riko Kitazawa; Ryuma Haraguchi; Mana Fukushima; Sohei Kitazawa
Journal:  Histochem Cell Biol       Date:  2018-01-22       Impact factor: 4.304

Review 9.  Targeting FcRn to Generate Antibody-Based Therapeutics.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Trends Pharmacol Sci       Date:  2018-08-22       Impact factor: 14.819

10.  The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review.

Authors:  Alessander Leyendecker; Carla Cristina Gomes Pinheiro; Mariane Tami Amano; Daniela Franco Bueno
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.